List of works - Maciej Sałaga

AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice

scientific article published on 15 May 2021

Anti-Inflammatory Effect of Homo- and Heterodimers of Natural Enkephalinase Inhibitors in Experimental Colitis in Mice

scientific article published on 10 December 2020

Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases

scientific article published on 4 April 2014

Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases

scientific article published on 17 December 2013

Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: new potential treatment of abdominal pain associated with inflammatory bowel diseases

scientific article published on 20 August 2014

Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice

scientific article published on 21 September 2015

Anti-inflammatory effect of novel analogs of natural enkephalinase inhibitors in a mouse model of experimental colitis

scientific article published on 15 November 2016

Characterization of the effects of opiorphin and sialorphin and their analogs substituted in position 1 with pyroglutamic acid on motility in the mouse ileum

scientific article published on 4 February 2013

Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review

scientific article

Chronic abdominal pain in irritable bowel syndrome - current and future therapies

scientific article published on 09 July 2018

Corrigendum to "Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system" [Biochem. Pharmacol. 161 (2019) 37-51]

scientific article published on 14 September 2019

Corrigendum to "The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome" [Eur. J. Pharmacol. (2018

scientific article published on 10 September 2019

Cross-talk between serotonin and cannabinoid signaling in the gut, new insights and future perspectives

scientific article published on 7 August 2014

Cyclic derivative of morphiceptin Dmt-cyclo-(D-Lys-Phe-D-Pro-Asp)-NH2(P-317), a mixed agonist of MOP and KOP opioid receptors, exerts anti-inflammatory and anti-tumor activity in colitis and colitis-associated colorectal cancer in mice

scientific article published on 21 August 2020

Dietary Carbohydrates and Lipids in the Pathogenesis of Leaky Gut Syndrome: An Overview

scientific article published on 08 November 2020

Dietary fatty acid content influences the expression of genes involved in the lipid turnover and inflammation in mouse colon and spleen

scientific article published on 29 July 2019

Efficacy and safety of serotonin receptor ligands in the treatment of irritable bowel syndrome: a review

scientific article published on 27 December 2017

Encenicline, an α7 Nicotinic Acetylcholine Receptor Partial Agonist, Reduces Immune Cell Infiltration in the Colon and Improves Experimental Colitis in Mice

scientific article published on 13 October 2015

Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study

scientific article published on 27 December 2013

Experimental colitis in mice is attenuated by topical administration of chlorogenic acid

scientific article published on 7 March 2015

Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease

scientific article published on 20 December 2020

Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain

Free Fatty Acid Receptors as new potential target in Colorectal Cancer

scientific article published on 12 November 2019

Free Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases

scientific article published on 14 December 2019

Genetic factors in pathogenesis, course and treatment of inflammatory bowel diseases

scientific article published on 17 March 2015

High activity of endogenous opioid system protects against gastric damage development in mouse models of gastric mucosal injury

scientific article published on 25 October 2018

High activity of the endogenous opioid system and acute but not chronic stress influence experimental colitis development in mice

scientific article published on 01 October 2018

Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice

scientific article published on 14 July 2017

Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract

scientific article

Inhibition of proteases as a novel therapeutic strategy in the treatment of metabolic, inflammatory and functional diseases of the gastrointestinal tract

scientific article published on 06 April 2013

Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner.

scientific article published on 7 December 2017

Management of pain in colorectal cancer patients

scientific article published on 19 October 2020

Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice

scientific article published on 22 February 2016

Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms

scientific article published on 12 June 2015

Neuropharmacological characterization of the oneirogenic Mexican plant Calea zacatechichi aqueous extract in mice

scientific article (publication date: June 2016)

New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration

scientific article published on 19 July 2017

Nociceptin / orphanin FQ (NOP) receptors as novel potential target in the treatment of gastrointestinal diseases

scientific article published on September 2013

Novel glycosylated endomorphin-2 analog produces potent centrally-mediated antinociception in mice after peripheral administration

scientific article published on 30 October 2013

Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review

scientific article

Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms

scientific article published on 6 May 2014

Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors

scientific article published on 6 October 2014

Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome

Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives

scientific article published on 09 February 2013

RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives

scientific article published on 28 January 2016

Recent advances in inflammatory bowel disease therapy

scientific article published on 13 September 2020

Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives

scientific article published on 29 July 2019

Role of transient receptor potential channels in intestinal inflammation and visceral pain: novel targets in inflammatory bowel diseases

scientific article

Silver nanoparticles based on blackcurrant extract show potent anti-inflammatory effect in vitro and in DSS-induced colitis in mice

scientific article published on 15 June 2020

Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system

scientific article published on 03 January 2019

T cell-activated signaling pathways and locally produced cytokines as potential targets in celiac disease

scientific article

The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome

scientific article published on 17 August 2018

The organisation and needs of young sections belonging to UEG National Societies: Results of a Europe-wide survey

scientific article published on 09 July 2017

UEG Young Talent Group: What do we do?

scientific article published on 30 January 2019

Walnut Oil Alleviates Intestinal Inflammation and Restores Intestinal Barrier Function in Mice

scientific article published on 02 May 2020

List of works by Maciej Sałaga

AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice

Anti-Inflammatory Effect of Homo- and Heterodimers of Natural Enkephalinase Inhibitors in Experimental Colitis in Mice

Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases

Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases

Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: new potential treatment of abdominal pain associated with inflammatory bowel diseases

Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice

Anti-inflammatory effect of novel analogs of natural enkephalinase inhibitors in a mouse model of experimental colitis

Characterization of the effects of opiorphin and sialorphin and their analogs substituted in position 1 with pyroglutamic acid on motility in the mouse ileum

Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review

Chronic abdominal pain in irritable bowel syndrome - current and future therapies

Corrigendum to "Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system" [Biochem. Pharmacol. 161 (2019) 37-51]

Corrigendum to "The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome" [Eur. J. Pharmacol. (2018

Cross-talk between serotonin and cannabinoid signaling in the gut, new insights and future perspectives

Cyclic derivative of morphiceptin Dmt-cyclo-(D-Lys-Phe-D-Pro-Asp)-NH2(P-317), a mixed agonist of MOP and KOP opioid receptors, exerts anti-inflammatory and anti-tumor activity in colitis and colitis-associated colorectal cancer in mice

Dietary Carbohydrates and Lipids in the Pathogenesis of Leaky Gut Syndrome: An Overview

Dietary fatty acid content influences the expression of genes involved in the lipid turnover and inflammation in mouse colon and spleen

Efficacy and safety of serotonin receptor ligands in the treatment of irritable bowel syndrome: a review

Encenicline, an α7 Nicotinic Acetylcholine Receptor Partial Agonist, Reduces Immune Cell Infiltration in the Colon and Improves Experimental Colitis in Mice

Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study

Experimental colitis in mice is attenuated by topical administration of chlorogenic acid

Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease

Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain

Free Fatty Acid Receptors as new potential target in Colorectal Cancer

Free Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases

Genetic factors in pathogenesis, course and treatment of inflammatory bowel diseases

High activity of endogenous opioid system protects against gastric damage development in mouse models of gastric mucosal injury

High activity of the endogenous opioid system and acute but not chronic stress influence experimental colitis development in mice

Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice

Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract

Inhibition of proteases as a novel therapeutic strategy in the treatment of metabolic, inflammatory and functional diseases of the gastrointestinal tract

Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner.

Management of pain in colorectal cancer patients

Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice

Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms

Neuropharmacological characterization of the oneirogenic Mexican plant Calea zacatechichi aqueous extract in mice

New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration

Nociceptin / orphanin FQ (NOP) receptors as novel potential target in the treatment of gastrointestinal diseases

Novel glycosylated endomorphin-2 analog produces potent centrally-mediated antinociception in mice after peripheral administration

Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review

Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms

Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors

Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome

Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome

Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives

RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives

Recent advances in inflammatory bowel disease therapy

Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives

Role of transient receptor potential channels in intestinal inflammation and visceral pain: novel targets in inflammatory bowel diseases

Silver nanoparticles based on blackcurrant extract show potent anti-inflammatory effect in vitro and in DSS-induced colitis in mice

Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system

T cell-activated signaling pathways and locally produced cytokines as potential targets in celiac disease

The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome

The organisation and needs of young sections belonging to UEG National Societies: Results of a Europe-wide survey

UEG Young Talent Group: What do we do?

Walnut Oil Alleviates Intestinal Inflammation and Restores Intestinal Barrier Function in Mice